16.9601.74% ( +0.290 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is 6.34, within the reasonable range, cheaper than 63.8% of the time in the past 5 years, and the industry ranks 1/22, the industry Median 6.34.
6.34xP/E
HK$16.96Stock price
HK$2.67Earnings per share
6.34xP/E
Stock priceHK$16.96Earnings per shareHK$2.67
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 6.69x
- Typical range
- 6.01x–7.66x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.34x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.34x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01099HKSINOPHARM | 6.34x | 10.33% | HK$52.93B |
02607HKSH PHARMA | 6.79x | -- | HK$40.87B |
00874HKBAIYUNSHAN PH | 8.12x | 8.46% | HK$20.48B |
06833HKSINCO PHARMA | 7.56x | -- | HK$264.28M |
03390HKTYCOON GROUP | 6.80x | -- | HK$209.20M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
